MD: Rasio rega marang prakiraan pendapatan Pediatrix Corp

Logo perusahaan publik MEDNAX (MD)

Pediatrix Medical stability is supported by efficient outsourcing of IT processes and billing. The company's P/S expectations visualize this trend, where 1.00 describes the current status of the metric. However, the business relies on the US market, which precludes sanctions but creates a shortage of imported equipment. Additionally, the company is pressured by low birth rates, labor shortages, and potential lawsuits.

Pediatrix Medical Group, Inc. - Rasio kapitalisasi marang dodolan sing dikarepake MD (periode 04.07.2022 - 13.11.2026)

Rincian metrik komprehensif lan analitis Pediatrix Corp (MD)

Analisis kabeh metrik perusahaan:Pediatrix Medical Group MD
Produk sing diprodhuksi Pediatrix Medical

High switching costs in neonatology provide Pediatrix Medical (MD) with a steady revenue stream, making revenue valuation critical. The organization's forward P/S on GURU.Markets compares current market value with expected sales, revealing the extent of the asset's overheating. This multiple measures the growth premium the market is willing to pay for the integration of services into hospital networks. A decline in this indicator signals that the business is undervalued relative to its operational significance.

Analisis pesaing

HCA Healthcare - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare Corp)|FMS - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan SOLV (Solventum Health)|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan DVA|Kapitalisasi marang prakiraan pendapatan RDNT (RadNet Inc)|Multiplikator forward rega marang pendapatan OPCH (Option Care Health Inc)|SGRY (Surgery Partners Group) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Premier, Inc. PINC|EYE - Multiplikator forward rega marang pendapatan|Progyny - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ardent Health|SEM: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ASTH|USPH (US Physical Therapy) - Multiplikator Forward P/S|pennantgroup.com (PNTG) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ORGO|Multiplikator forward rega marang pendapatan Nutex Health Inc NUTX|Multiplikator Forward P/S AUNA (Auna Health)|Multiplikator Forward P/S SBC Medical Group Holdings SBC|EOLS - Rasio rega marang prakiraan pendapatan|CYH: Rasio rega marang prakiraan pendapatan|beautyhealth.com (SKIN) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan MediWound|BTMD (Biote Corp) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan JYNT (The Joint)|Multiplikator forward rega marang pendapatan DCGO (DocGo Inc.)|Rasio rega marang pendapatan sing dikarepake PIII|Rasio rega marang prakiraan pendapatan Gain Therapeutics GANX|Rega forward marang dodolan EUDA|Basel Medical Group Limited - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CollPlant Biotechnologies|CUPR: Multiplikator Forward P/S|concordmedical.com (CCM) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan AMS|MRM (MEDIROM Healthcare Group Inc.) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Avalon GloboCare (ALBT)|Multiplikator forward rega marang pendapatan DIH Group DHAI|Multiplikator Forward P/S XAGE (Longevity Health Holdings)|newgenivf.com (NIVF) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ATIP - Rasio rega marang prakiraan pendapatan|CMAX (CareMax Inc.) - Kapitalisasi marang prakiraan pendapatan|KDLY (Kindly MD Corp) - Multiplikator forward rega marang pendapatan|MODV: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences|SunLink Health Systems, Inc - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S BACK